Evidence map›Paper›PMID 25336653›Full record

ArticleThe Journal of biological chemistry2014

SbnG, a citrate synthase in Staphylococcus aureus: a new fold on an old enzyme.

Marek J Kobylarz, Jason C Grigg, Jessica R Sheldon, David E Heinrichs, Michael E P Murphy

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. The steroid side-chain-cleaving aldolase Ltp2-ChsH2The Journal of biological chemistry · 2019
    Article
  5. SbnI is a free serine kinase that generatesThe Journal of biological chemistry · 2018
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marek J KobylarzFrom the Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada and.
Jason C GriggFrom the Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada and.
Jessica R Sheldonthe Department of Microbiology and Immunology and.
David E Heinrichsthe Department of Microbiology and Immunology and the Centre for Human Immunology University of Western Ontario, London, Ontario N6A 5C1, Canada.
Michael E P MurphyFrom the Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada and Michael.Murphy@ubc.ca.
University of British Columbia · CAWestern University · CA

Funding

ZWITTERION SURFACTANT DDMAB FOR IMPROV STABIL OF PROTEINP41RR001209 · NCRR · STANFORD UNIVERSITY · PI REESE, MICHAEL LLOYD · 1985 to 2011
$38.9M
CIHR MOP-102596NCRR NIH HHS P41 RR001209NCRR NIH HHS P41RR001209
6 · The paper itself

Abstract

In response to iron deprivation, Staphylococcus aureus produces staphyloferrin B, a citrate-containing siderophore that delivers iron back to the cell. This bacterium also possesses a second citrate synthase, SbnG, that is necessary for supplying citrate to the staphyloferrin B biosynthetic pathway. We present the structure of SbnG bound to the inhibitor calcium and an active site variant in complex with oxaloacetate. The overall fold of SbnG is structurally distinct from TCA cycle citrate synthases yet similar to metal-dependent class II aldolases. Phylogenetic analyses revealed that SbnG forms a separate clade with homologs from other siderophore biosynthetic gene clusters and is representative of a metal-independent subgroup in the phosphoenolpyruvate/pyruvate domain superfamily. A structural superposition of the SbnG active site to TCA cycle citrate synthases and site-directed mutagenesis suggests a case for convergent evolution toward a conserved catalytic mechanism for citrate production.

Indexed as

Amino Acid SequenceBacterial ProteinsCitratesCitrate (si)-SynthaseCitric Acid CycleCrystallography, X-RayEscherichia coliEvolution, MolecularGene ExpressionIronIron-Regulatory ProteinsModels, MolecularMolecular Sequence DataOxaloacetic AcidPhosphoenolpyruvatePhylogenyBacterial ProteinsCitratesCitrate (si)-SynthaseIronIron-Regulatory ProteinsOxaloacetic AcidPhosphoenolpyruvatePyruvic AcidRecombinant Proteinsstaphyloferrin BCitrate SynthaseConvergent EvolutionCrystal StructureIronSiderophoreStaphylococcus aureus (S. aureus)Tricarboxylic Acid Cycle (TCA Cycle) (Krebs Cycle)

Identifiers

PMID25336653
PMCPMC4256314
OpenAlexW2059430496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.